Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for overweight patients with knee osteoarthritis
IRCT20200522047538N2Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) and knee osteoarthritis (OA) comparing Metformin with Placebo (2 arms). Primary endpoints: WOMAC index and VAS pain score. Started Feb 2024; status: completed.
02
Drugs
metformin
03
Conditions
osteoarthritis (OA)knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20200522047538N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200522047538N2.